BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1387074)

  • 1. Lipoprotein(a) in diabetic patients with and without chronic renal failure.
    Guillausseau PJ; Peynet J; Chanson P; Legrand A; Altman JJ; Poupon J; N'Guyen M; Rousselet F; Lubetzki J
    Diabetes Care; 1992 Aug; 15(8):976-9. PubMed ID: 1387074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
    Wollesen F; Dahlén G; Berglund L; Berne C
    Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM.
    Austin A; Warty V; Janosky J; Arslanian S
    Diabetes Care; 1993 Feb; 16(2):421-5. PubMed ID: 8432211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group.
    Diabetes Care; 1992 Jul; 15(7):886-94. PubMed ID: 1516509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol, HDL-cholesterol, triglycerides and beta-lipoprotein in diabetic pregnancy].
    Briese V; Müller H; Stiete H
    Zentralbl Gynakol; 1995; 117(1):17-22. PubMed ID: 7879456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
    Laakso M; Pyörälä K
    Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipoprotein(a) in patients with diabetes mellitus.
    Heller FR; Jamart J; Honore P; Derue G; Novik V; Galanti L; Parfonry A; Hondekijn JC; Buysschaert M
    Diabetes Care; 1993 May; 16(5):819-23. PubMed ID: 8495624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum LpAI lipoprotein particles in diabetic patients with and without renal lesions of different grades.
    Peynet J; Guillausseau PJ; Legrand A; Altman JJ; Flourie F; Chanson P; Poupon J; N'Guyen M; Warnet A; Lubetzki J
    Diabete Metab; 1993; 19(4):355-60. PubMed ID: 8293861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.
    Idzior-Walus B; Mattock MB; Solnica B; Stevens L; Fuller JH;
    Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
    Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
    Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
    Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
    Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for retardation of renal function in IDDM and NIDDM with nephropathy.
    Hara S; Arizono K; Ubara Y; Morita T; Suzuki Y; Ogura Y; Hagura R; Akanuma Y
    J Diabet Complications; 1991; 5(2-3):131-3. PubMed ID: 1770020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids, lipoproteins, antioxidants and glomerular and tubular dysfunction in type 1 diabetes.
    O'Brien SF; Watts GF; Powrie JK; Shaw KM; Miller NJ
    Diabetes Res Clin Pract; 1996 Apr; 32(1-2):81-90. PubMed ID: 8803485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of insulin-dependent diabetes on plasma lipoproteins in diabetic pregnancy.
    Knopp RH; Van Allen MI; McNeely M; Walden CE; Plovie B; Shiota K; Brown Z
    J Reprod Med; 1993 Sep; 38(9):703-10. PubMed ID: 8254593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus.
    O'Brien T; Nguyen TT; Harrison JM; Bailey KR; Dyck PJ; Kottke BA
    Mayo Clin Proc; 1994 May; 69(5):430-5. PubMed ID: 8170193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.